Distribution of liposomal bifendate in liver following intravenous injection in mice

Journal of Drug Targeting

Volumn 18, Issue 8, 2010, Pages 627-636

  Zhipeng, C ^a,b   Jiabi, Z ^b   Hongxuan, C ^c   Yan Yu, X ^b   Jun, C ^a   Bao Chang, Cai ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c HENAN UNIVERSITY   (China)

Author keywords

Biodistribution; drug targeting; liposomes; liver targeting; pharmacokinetics

Indexed keywords

BIFENDATE; LIPOSOME; SCHIZANDRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG RELEASE; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; LIVER; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE; ZETA POTENTIAL;

ANIMALS; AREA UNDER CURVE; BIPHENYL COMPOUNDS; DRUG STABILITY; INJECTIONS, INTRAVENOUS; LIPOSOMES; LIVER; MALE; MICE; PARTICLE SIZE; RATS; RATS, WISTAR;

EID: 77955198606     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003639788     Document Type: Article

References (23)

1. Baek MS, Kim JY, Myung SW, Yim YH, Jeong JH, Kim DH. (2001). Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'- dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved. Drug Metab Dispos, 29, 381-388.
2. Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13, 238-252.
3. Castile JD, Taylor KM, Buckton G. (2001). The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants. Int J Pharm, 221, 197-209.
4. Chi SC, Yeom DI, Kim SC, Park ES. (2003). A polymeric micellar carrier for the solubilization of biphenyl dimethyl dicarboxylate. Arch Pharm Res, 26, 173-181.
5. Hyun J, Chun IK. (1994). Dissolution characteristics of biphenyl dimethyl dicarboxylate from solid dispersion and permeation through rabbit duodenal mucosa. J Kor Pharm Sci, 24, 57-65.
6. Ip SP, Yiu HY, Ko KM. (2000). Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochon- drial glutathione redox status in carbon tetrachloride intoxicated mice. Mol Cell Biochem, 205, 111-114.
7. Joo SS, Won TJ, Kim MJ, Hwang KW, Lee do I. (2006). Interferon signal transduction of biphenyl dimethyl dicarboxylate/amanta- dine and anti-HBV activity in HepG2 2.2.15. Arch Pharm Res, 29, 405-411.
8. Kim JY, Baek M, Lee S, et al. (2001). Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5', 6'-dimethylenedioxybiphenyl- 2,2'-dicarboxylate. Drug Metab Dispos, 29, 1555-1560.
9. Kim SG, Kim HJ, Choi SH, Ryu JY. (2000). Inhibition of lipopolysac- charide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4,4'-dimethoxy-5,6,5',6'- dimethylene dioxybiphenyl-2,2'- dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression. Liver, 20, 319-329.
10. Lange Y, Steck TL. (2008). Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol. Prog Lipid Res, 47, 319-332.
11. Lee KJ, Kim JR, Lee CH. (2005). Effect of 2-methylaminoethyl-4,4'- dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2-carboxylic acid-2'-carboxylate monohydrochloride (DDB-S) on indo- cyanine green (ICG) clearance in rats. Arch Pharm Res, 28, 115-119.
12. Liu GT. (1989). Pharmacological actions and clinical use of fructus schizandrae. Chin Med J, 102, 740-749.
13. Lu H, Liu GT. (1991). Effect of dibenzo[a,c]cyclooctene lignans isolated from Fructus schizandrae on lipid peroxidation and anti-oxida- tive enzyme activity. Chem Biol Interact, 78, 77-84.
14. Lv W, Guo J, Li J, Huang L, Ping Q. (2005). Distribution of liposomal breviscapine in brain following intravenous injection in rats. Int J Pharm, 306, 99-106.
15. Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. (2003). Preparation, characterization, cytotoxicity and pharmacokinet- ics of liposomes containing docetaxel. J Control Release, 91, 417-429.
16. Park EY, Ki SH, Ko MS, et al. (2005). Garlic oil and DDB, comprised in a pharmaceutical composition for the treatment of patients with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats. Chem Biol Interact, 155, 82-96.
17. Qi X, Wang X, Wang L, Wang Q, Cheng S, Suo J, Chang J. (2005). A solid- phase approach to DDB derivatives. Eur J Med Chem, 40, 805-810.
18. Rahman A, Carmichael D, Harris M, Roh JK. (1986). Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Res, 46, 2295-2299. (Pubitemid 16120685)
19. Redhead HM, Davis SS, Illum L. (2001). Drug delivery in poly(lactide- co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release, 70, 353-363.
20. Shah NB, Sheth BB. (1972). A method for study of timed-release films. J Pharm Sci, 61, 412-416.
21. Socaciu C, Jessel R, Diehl HA. (2000). Competitive carotenoid and cholesterol incorporation into liposomes: effects on membrane phase transition, fluidity, polarity and anisotropy. Chem Phys Lipids, 106, 79-88.
22. Wang XL, Yi MG, Liu ZM, Song ZY. (1983). Absorption, distribution and excretion of biphenyl dimethyl-dicarboxylate (BDD). Yao Xue Xue Bao, 18, 892-899.
23. Zhang JA, Pawelchak J. (2000). Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1: Lipid hydrolysis. Eur J Pharm Biopharm, 50, 357-364.